The impact of cirrhosis in patients undergoing cardiac surgery: a retrospective observational cohort study

Sheela Xavier1, Colleen M Norris2, Amanda Ewasiuk1

  • 1Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2X8, Canada.

Insights

Patients with cirrhosis undergoing cardiac surgery face higher mortality and complication risks. This study highlights increased postoperative complications and resource needs in cirrhotic patients, emphasizing the impact of liver disease on surgical outcomes.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation

Background:

  • Patients with cirrhosis and heart disease present a complex clinical challenge.
  • Major cardiac surgery outcomes are significantly poorer in patients with cirrhosis.

Purpose of the Study:

  • To investigate the association between cirrhosis severity and post-cardiac surgical outcomes.
  • To evaluate the impact of cirrhosis on mortality, complications, and healthcare resource utilization after cardiac surgery.

Main Methods:

  • A historical cohort analysis was conducted from January 2004 to December 2014.
  • Sixty patients with cirrhosis were propensity score-matched to 310 patients without cirrhosis.
  • Outcomes evaluated included mortality, postoperative complications, and healthcare resource requirements.

Main Results:

  • Ten-year mortality was significantly higher in cirrhotic patients (40% vs. 20%).
  • Cirrhotic patients experienced more complications (63% vs. 48%) and longer intensive care unit stays.
  • Cirrhosis and intraoperative transfusion were independently associated with increased mortality.

Conclusions:

  • Cirrhotic patients undergoing cardiac surgery have significantly higher mortality and require more organ support, even with low Model for End-Stage Liver Disease scores.
  • Cirrhosis presence is an independent predictor of increased mortality post-cardiac surgery.
  • These findings underscore the critical impact of liver disease on cardiac surgical outcomes.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
248
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
334
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
193